Reflections on Alnylam
Nat Biotechnol
.
2022 May;40(5):641-650.
doi: 10.1038/s41587-022-01304-3.
Author
John Maraganore
1
Affiliation
1
Former founding CEO, Alnylam Pharmaceuticals, Cambridge, MA, USA.
[email protected]
.
PMID:
35534556
DOI:
10.1038/s41587-022-01304-3
No abstract available